# Cylex

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cylex

- Industry: Healthcare
- Headquarters: Columbia, US
- Website: www.cylex.net
- Total disclosed funding: $33M
- Latest round: Series C (Mar 14, 2007)
- Investors on record: 13

## About

Originally founded in 1992, Cylex is a global life sciences company based in Columbia, US. Cylex develops, manufactures and commercializes in vitro diagnostic products intended to illuminate immunity in the area of transplant medicine.

## Funding rounds

- Series C, Mar 14, 2007, $21M — First Analysis, N47, Canaan Partners, Channel Medical Partners, Tech Council Ventures, Maryland Department of Business and Economic Development, Calvert Research and Management, Roche Venture Fund, Early Stage Enterprises, LP, The Washington Dinner Club Fund, Cahn Medical Technologies, Chesapeake Emerging Opportunities
- Series B, Sep 7, 2004, $6.4M — Tech Council Ventures, Roche Venture Fund, Early Stage Enterprises, LP
- Series A, Aug 1, 1999, $6M — H.I.G. BioHealth Partners

## Investors

- H.I.G. BioHealth Partners (https://capitalatlas.ai/funds/h-i-g-biohealth-partners) — Series A
- Tech Council Ventures (https://capitalatlas.ai/funds/tech-council-ventures) — Series B, Series C
- Roche Venture Fund (https://capitalatlas.ai/funds/roche-venture-fund) — Series B, Series C
- Early Stage Enterprises, LP — Series B, Series C
- First Analysis (https://capitalatlas.ai/funds/first-analysis) — Series C
- N47 (https://capitalatlas.ai/funds/n47) — Series C
- Canaan Partners (https://capitalatlas.ai/funds/canaan-partners) — Series C
- Channel Medical Partners (https://capitalatlas.ai/funds/channel-medical-partners) — Series C
- Maryland Department of Business and Economic Development — Series C
- Calvert Research and Management — Series C
- The Washington Dinner Club Fund — Series C
- Cahn Medical Technologies — Series C
- Chesapeake Emerging Opportunities — Series C